Global Cell and Gene Therapy CDMO Supply, Demand and Key Producers, 2023-2029
The global Cell and Gene Therapy CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Cell and Gene Therapy CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy CDMO total market, 2018-2029, (USD Million)
Global Cell and Gene Therapy CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell and Gene Therapy CDMO total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy CDMO revenue by player and market share 2018-2023, (USD Million)
Global Cell and Gene Therapy CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell and Gene Therapy CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Cell and Gene Therapy CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Charles River Laboratories, Cytiva, Catalent Biologics, FUJIFILM Diosynth Biotechnologies, BioCentriq, RoslinCT, Thermo Scientific and Mesoblast, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell and Gene Therapy CDMO Market, By Region:
1. How big is the global Cell and Gene Therapy CDMO market?
2. What is the demand of the global Cell and Gene Therapy CDMO market?
3. What is the year over year growth of the global Cell and Gene Therapy CDMO market?
4. What is the total value of the global Cell and Gene Therapy CDMO market?
5. Who are the major players in the global Cell and Gene Therapy CDMO market?
This report studies the global Cell and Gene Therapy CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cell and Gene Therapy CDMO total market, 2018-2029, (USD Million)
Global Cell and Gene Therapy CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cell and Gene Therapy CDMO total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy CDMO revenue by player and market share 2018-2023, (USD Million)
Global Cell and Gene Therapy CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Cell and Gene Therapy CDMO total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Cell and Gene Therapy CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Charles River Laboratories, Cytiva, Catalent Biologics, FUJIFILM Diosynth Biotechnologies, BioCentriq, RoslinCT, Thermo Scientific and Mesoblast, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy CDMO market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cell and Gene Therapy CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Clinical Trial Material CDMOs
- Development and Manufacturing CDMOs
- Other
- Pharmaceutical Company
- Biotechnology Company
- Other
- Lonza
- Charles River Laboratories
- Cytiva
- Catalent Biologics
- FUJIFILM Diosynth Biotechnologies
- BioCentriq
- RoslinCT
- Thermo Scientific
- Mesoblast
- Cellularity
- Bluebird Bio
- Editas Medicine
- Andelyn Biosciences
- Wuxi Advanced Therapies
- AGC Biologics
- Pfizer CentreOne
- Almac Group
- PCI Pharma Services
1. How big is the global Cell and Gene Therapy CDMO market?
2. What is the demand of the global Cell and Gene Therapy CDMO market?
3. What is the year over year growth of the global Cell and Gene Therapy CDMO market?
4. What is the total value of the global Cell and Gene Therapy CDMO market?
5. Who are the major players in the global Cell and Gene Therapy CDMO market?
1 SUPPLY SUMMARY
1.1 Cell and Gene Therapy CDMO Introduction
1.2 World Cell and Gene Therapy CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell and Gene Therapy CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.3 China Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.4 Europe Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.5 Japan Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.6 South Korea Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.7 ASEAN Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.8 India Cell and Gene Therapy CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell and Gene Therapy CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.2 World Cell and Gene Therapy CDMO Consumption Value by Region
2.2.1 World Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023)
2.2.2 World Cell and Gene Therapy CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.4 China Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.5 Europe Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.6 Japan Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.7 South Korea Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.8 ASEAN Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.9 India Cell and Gene Therapy CDMO Consumption Value (2018-2029)
3 WORLD CELL AND GENE THERAPY CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy CDMO in 2022
3.3 Cell and Gene Therapy CDMO Company Evaluation Quadrant
3.4 Cell and Gene Therapy CDMO Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy CDMO Market: Region Footprint
3.4.2 Cell and Gene Therapy CDMO Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy CDMO Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell and Gene Therapy CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell and Gene Therapy CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Cell and Gene Therapy CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023)
4.4 China Based Companies Cell and Gene Therapy CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Cell and Gene Therapy CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023)
4.5 Rest of World Based Cell and Gene Therapy CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell and Gene Therapy CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Clinical Trial Material CDMOs
5.2.2 Development and Manufacturing CDMOs
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
5.3.2 World Cell and Gene Therapy CDMO Market Size by Type (2024-2029)
5.3.3 World Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell and Gene Therapy CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
6.3.2 World Cell and Gene Therapy CDMO Market Size by Application (2024-2029)
6.3.3 World Cell and Gene Therapy CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Cell and Gene Therapy CDMO Product and Services
7.1.4 Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Charles River Laboratories
7.2.1 Charles River Laboratories Details
7.2.2 Charles River Laboratories Major Business
7.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Product and Services
7.2.4 Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Charles River Laboratories Recent Developments/Updates
7.2.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.3 Cytiva
7.3.1 Cytiva Details
7.3.2 Cytiva Major Business
7.3.3 Cytiva Cell and Gene Therapy CDMO Product and Services
7.3.4 Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Cytiva Recent Developments/Updates
7.3.6 Cytiva Competitive Strengths & Weaknesses
7.4 Catalent Biologics
7.4.1 Catalent Biologics Details
7.4.2 Catalent Biologics Major Business
7.4.3 Catalent Biologics Cell and Gene Therapy CDMO Product and Services
7.4.4 Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Catalent Biologics Recent Developments/Updates
7.4.6 Catalent Biologics Competitive Strengths & Weaknesses
7.5 FUJIFILM Diosynth Biotechnologies
7.5.1 FUJIFILM Diosynth Biotechnologies Details
7.5.2 FUJIFILM Diosynth Biotechnologies Major Business
7.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Services
7.5.4 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.5.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.6 BioCentriq
7.6.1 BioCentriq Details
7.6.2 BioCentriq Major Business
7.6.3 BioCentriq Cell and Gene Therapy CDMO Product and Services
7.6.4 BioCentriq Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 BioCentriq Recent Developments/Updates
7.6.6 BioCentriq Competitive Strengths & Weaknesses
7.7 RoslinCT
7.7.1 RoslinCT Details
7.7.2 RoslinCT Major Business
7.7.3 RoslinCT Cell and Gene Therapy CDMO Product and Services
7.7.4 RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 RoslinCT Recent Developments/Updates
7.7.6 RoslinCT Competitive Strengths & Weaknesses
7.8 Thermo Scientific
7.8.1 Thermo Scientific Details
7.8.2 Thermo Scientific Major Business
7.8.3 Thermo Scientific Cell and Gene Therapy CDMO Product and Services
7.8.4 Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Scientific Recent Developments/Updates
7.8.6 Thermo Scientific Competitive Strengths & Weaknesses
7.9 Mesoblast
7.9.1 Mesoblast Details
7.9.2 Mesoblast Major Business
7.9.3 Mesoblast Cell and Gene Therapy CDMO Product and Services
7.9.4 Mesoblast Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Mesoblast Recent Developments/Updates
7.9.6 Mesoblast Competitive Strengths & Weaknesses
7.10 Cellularity
7.10.1 Cellularity Details
7.10.2 Cellularity Major Business
7.10.3 Cellularity Cell and Gene Therapy CDMO Product and Services
7.10.4 Cellularity Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Cellularity Recent Developments/Updates
7.10.6 Cellularity Competitive Strengths & Weaknesses
7.11 Bluebird Bio
7.11.1 Bluebird Bio Details
7.11.2 Bluebird Bio Major Business
7.11.3 Bluebird Bio Cell and Gene Therapy CDMO Product and Services
7.11.4 Bluebird Bio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bluebird Bio Recent Developments/Updates
7.11.6 Bluebird Bio Competitive Strengths & Weaknesses
7.12 Editas Medicine
7.12.1 Editas Medicine Details
7.12.2 Editas Medicine Major Business
7.12.3 Editas Medicine Cell and Gene Therapy CDMO Product and Services
7.12.4 Editas Medicine Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Editas Medicine Recent Developments/Updates
7.12.6 Editas Medicine Competitive Strengths & Weaknesses
7.13 Andelyn Biosciences
7.13.1 Andelyn Biosciences Details
7.13.2 Andelyn Biosciences Major Business
7.13.3 Andelyn Biosciences Cell and Gene Therapy CDMO Product and Services
7.13.4 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Andelyn Biosciences Recent Developments/Updates
7.13.6 Andelyn Biosciences Competitive Strengths & Weaknesses
7.14 Wuxi Advanced Therapies
7.14.1 Wuxi Advanced Therapies Details
7.14.2 Wuxi Advanced Therapies Major Business
7.14.3 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Services
7.14.4 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Wuxi Advanced Therapies Recent Developments/Updates
7.14.6 Wuxi Advanced Therapies Competitive Strengths & Weaknesses
7.15 AGC Biologics
7.15.1 AGC Biologics Details
7.15.2 AGC Biologics Major Business
7.15.3 AGC Biologics Cell and Gene Therapy CDMO Product and Services
7.15.4 AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 AGC Biologics Recent Developments/Updates
7.15.6 AGC Biologics Competitive Strengths & Weaknesses
7.16 Pfizer CentreOne
7.16.1 Pfizer CentreOne Details
7.16.2 Pfizer CentreOne Major Business
7.16.3 Pfizer CentreOne Cell and Gene Therapy CDMO Product and Services
7.16.4 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Pfizer CentreOne Recent Developments/Updates
7.16.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.17 Almac Group
7.17.1 Almac Group Details
7.17.2 Almac Group Major Business
7.17.3 Almac Group Cell and Gene Therapy CDMO Product and Services
7.17.4 Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Almac Group Recent Developments/Updates
7.17.6 Almac Group Competitive Strengths & Weaknesses
7.18 PCI Pharma Services
7.18.1 PCI Pharma Services Details
7.18.2 PCI Pharma Services Major Business
7.18.3 PCI Pharma Services Cell and Gene Therapy CDMO Product and Services
7.18.4 PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 PCI Pharma Services Recent Developments/Updates
7.18.6 PCI Pharma Services Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell and Gene Therapy CDMO Industry Chain
8.2 Cell and Gene Therapy CDMO Upstream Analysis
8.3 Cell and Gene Therapy CDMO Midstream Analysis
8.4 Cell and Gene Therapy CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cell and Gene Therapy CDMO Introduction
1.2 World Cell and Gene Therapy CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cell and Gene Therapy CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Cell and Gene Therapy CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.3 China Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.4 Europe Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.5 Japan Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.6 South Korea Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.7 ASEAN Cell and Gene Therapy CDMO Market Size (2018-2029)
1.3.8 India Cell and Gene Therapy CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cell and Gene Therapy CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cell and Gene Therapy CDMO Major Market Trends
2 DEMAND SUMMARY
2.1 World Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.2 World Cell and Gene Therapy CDMO Consumption Value by Region
2.2.1 World Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023)
2.2.2 World Cell and Gene Therapy CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.4 China Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.5 Europe Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.6 Japan Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.7 South Korea Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.8 ASEAN Cell and Gene Therapy CDMO Consumption Value (2018-2029)
2.9 India Cell and Gene Therapy CDMO Consumption Value (2018-2029)
3 WORLD CELL AND GENE THERAPY CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Cell and Gene Therapy CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cell and Gene Therapy CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy CDMO in 2022
3.3 Cell and Gene Therapy CDMO Company Evaluation Quadrant
3.4 Cell and Gene Therapy CDMO Market: Overall Company Footprint Analysis
3.4.1 Cell and Gene Therapy CDMO Market: Region Footprint
3.4.2 Cell and Gene Therapy CDMO Market: Company Product Type Footprint
3.4.3 Cell and Gene Therapy CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cell and Gene Therapy CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cell and Gene Therapy CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cell and Gene Therapy CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy CDMO Consumption Value Comparison
4.2.1 United States VS China: Cell and Gene Therapy CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cell and Gene Therapy CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cell and Gene Therapy CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Cell and Gene Therapy CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023)
4.4 China Based Companies Cell and Gene Therapy CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Cell and Gene Therapy CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023)
4.5 Rest of World Based Cell and Gene Therapy CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cell and Gene Therapy CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cell and Gene Therapy CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Clinical Trial Material CDMOs
5.2.2 Development and Manufacturing CDMOs
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Cell and Gene Therapy CDMO Market Size by Type (2018-2023)
5.3.2 World Cell and Gene Therapy CDMO Market Size by Type (2024-2029)
5.3.3 World Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cell and Gene Therapy CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Cell and Gene Therapy CDMO Market Size by Application (2018-2023)
6.3.2 World Cell and Gene Therapy CDMO Market Size by Application (2024-2029)
6.3.3 World Cell and Gene Therapy CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Lonza
7.1.1 Lonza Details
7.1.2 Lonza Major Business
7.1.3 Lonza Cell and Gene Therapy CDMO Product and Services
7.1.4 Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Lonza Recent Developments/Updates
7.1.6 Lonza Competitive Strengths & Weaknesses
7.2 Charles River Laboratories
7.2.1 Charles River Laboratories Details
7.2.2 Charles River Laboratories Major Business
7.2.3 Charles River Laboratories Cell and Gene Therapy CDMO Product and Services
7.2.4 Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Charles River Laboratories Recent Developments/Updates
7.2.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.3 Cytiva
7.3.1 Cytiva Details
7.3.2 Cytiva Major Business
7.3.3 Cytiva Cell and Gene Therapy CDMO Product and Services
7.3.4 Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Cytiva Recent Developments/Updates
7.3.6 Cytiva Competitive Strengths & Weaknesses
7.4 Catalent Biologics
7.4.1 Catalent Biologics Details
7.4.2 Catalent Biologics Major Business
7.4.3 Catalent Biologics Cell and Gene Therapy CDMO Product and Services
7.4.4 Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Catalent Biologics Recent Developments/Updates
7.4.6 Catalent Biologics Competitive Strengths & Weaknesses
7.5 FUJIFILM Diosynth Biotechnologies
7.5.1 FUJIFILM Diosynth Biotechnologies Details
7.5.2 FUJIFILM Diosynth Biotechnologies Major Business
7.5.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Services
7.5.4 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.5.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.6 BioCentriq
7.6.1 BioCentriq Details
7.6.2 BioCentriq Major Business
7.6.3 BioCentriq Cell and Gene Therapy CDMO Product and Services
7.6.4 BioCentriq Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 BioCentriq Recent Developments/Updates
7.6.6 BioCentriq Competitive Strengths & Weaknesses
7.7 RoslinCT
7.7.1 RoslinCT Details
7.7.2 RoslinCT Major Business
7.7.3 RoslinCT Cell and Gene Therapy CDMO Product and Services
7.7.4 RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 RoslinCT Recent Developments/Updates
7.7.6 RoslinCT Competitive Strengths & Weaknesses
7.8 Thermo Scientific
7.8.1 Thermo Scientific Details
7.8.2 Thermo Scientific Major Business
7.8.3 Thermo Scientific Cell and Gene Therapy CDMO Product and Services
7.8.4 Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Thermo Scientific Recent Developments/Updates
7.8.6 Thermo Scientific Competitive Strengths & Weaknesses
7.9 Mesoblast
7.9.1 Mesoblast Details
7.9.2 Mesoblast Major Business
7.9.3 Mesoblast Cell and Gene Therapy CDMO Product and Services
7.9.4 Mesoblast Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Mesoblast Recent Developments/Updates
7.9.6 Mesoblast Competitive Strengths & Weaknesses
7.10 Cellularity
7.10.1 Cellularity Details
7.10.2 Cellularity Major Business
7.10.3 Cellularity Cell and Gene Therapy CDMO Product and Services
7.10.4 Cellularity Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Cellularity Recent Developments/Updates
7.10.6 Cellularity Competitive Strengths & Weaknesses
7.11 Bluebird Bio
7.11.1 Bluebird Bio Details
7.11.2 Bluebird Bio Major Business
7.11.3 Bluebird Bio Cell and Gene Therapy CDMO Product and Services
7.11.4 Bluebird Bio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Bluebird Bio Recent Developments/Updates
7.11.6 Bluebird Bio Competitive Strengths & Weaknesses
7.12 Editas Medicine
7.12.1 Editas Medicine Details
7.12.2 Editas Medicine Major Business
7.12.3 Editas Medicine Cell and Gene Therapy CDMO Product and Services
7.12.4 Editas Medicine Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Editas Medicine Recent Developments/Updates
7.12.6 Editas Medicine Competitive Strengths & Weaknesses
7.13 Andelyn Biosciences
7.13.1 Andelyn Biosciences Details
7.13.2 Andelyn Biosciences Major Business
7.13.3 Andelyn Biosciences Cell and Gene Therapy CDMO Product and Services
7.13.4 Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Andelyn Biosciences Recent Developments/Updates
7.13.6 Andelyn Biosciences Competitive Strengths & Weaknesses
7.14 Wuxi Advanced Therapies
7.14.1 Wuxi Advanced Therapies Details
7.14.2 Wuxi Advanced Therapies Major Business
7.14.3 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Services
7.14.4 Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Wuxi Advanced Therapies Recent Developments/Updates
7.14.6 Wuxi Advanced Therapies Competitive Strengths & Weaknesses
7.15 AGC Biologics
7.15.1 AGC Biologics Details
7.15.2 AGC Biologics Major Business
7.15.3 AGC Biologics Cell and Gene Therapy CDMO Product and Services
7.15.4 AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 AGC Biologics Recent Developments/Updates
7.15.6 AGC Biologics Competitive Strengths & Weaknesses
7.16 Pfizer CentreOne
7.16.1 Pfizer CentreOne Details
7.16.2 Pfizer CentreOne Major Business
7.16.3 Pfizer CentreOne Cell and Gene Therapy CDMO Product and Services
7.16.4 Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Pfizer CentreOne Recent Developments/Updates
7.16.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.17 Almac Group
7.17.1 Almac Group Details
7.17.2 Almac Group Major Business
7.17.3 Almac Group Cell and Gene Therapy CDMO Product and Services
7.17.4 Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Almac Group Recent Developments/Updates
7.17.6 Almac Group Competitive Strengths & Weaknesses
7.18 PCI Pharma Services
7.18.1 PCI Pharma Services Details
7.18.2 PCI Pharma Services Major Business
7.18.3 PCI Pharma Services Cell and Gene Therapy CDMO Product and Services
7.18.4 PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 PCI Pharma Services Recent Developments/Updates
7.18.6 PCI Pharma Services Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cell and Gene Therapy CDMO Industry Chain
8.2 Cell and Gene Therapy CDMO Upstream Analysis
8.3 Cell and Gene Therapy CDMO Midstream Analysis
8.4 Cell and Gene Therapy CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cell and Gene Therapy CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell and Gene Therapy CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell and Gene Therapy CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell and Gene Therapy CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy CDMO Players in 2022
Table 12. World Cell and Gene Therapy CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell and Gene Therapy CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy CDMO Player
Table 15. Cell and Gene Therapy CDMO Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy CDMO Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell and Gene Therapy CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 23. China Based Cell and Gene Therapy CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell and Gene Therapy CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 29. World Cell and Gene Therapy CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell and Gene Therapy CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell and Gene Therapy CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell and Gene Therapy CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Cell and Gene Therapy CDMO Product and Services
Table 38. Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Charles River Laboratories Basic Information, Area Served and Competitors
Table 42. Charles River Laboratories Major Business
Table 43. Charles River Laboratories Cell and Gene Therapy CDMO Product and Services
Table 44. Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Charles River Laboratories Recent Developments/Updates
Table 46. Charles River Laboratories Competitive Strengths & Weaknesses
Table 47. Cytiva Basic Information, Area Served and Competitors
Table 48. Cytiva Major Business
Table 49. Cytiva Cell and Gene Therapy CDMO Product and Services
Table 50. Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Cytiva Recent Developments/Updates
Table 52. Cytiva Competitive Strengths & Weaknesses
Table 53. Catalent Biologics Basic Information, Area Served and Competitors
Table 54. Catalent Biologics Major Business
Table 55. Catalent Biologics Cell and Gene Therapy CDMO Product and Services
Table 56. Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Catalent Biologics Recent Developments/Updates
Table 58. Catalent Biologics Competitive Strengths & Weaknesses
Table 59. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 60. FUJIFILM Diosynth Biotechnologies Major Business
Table 61. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Services
Table 62. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 64. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 65. BioCentriq Basic Information, Area Served and Competitors
Table 66. BioCentriq Major Business
Table 67. BioCentriq Cell and Gene Therapy CDMO Product and Services
Table 68. BioCentriq Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. BioCentriq Recent Developments/Updates
Table 70. BioCentriq Competitive Strengths & Weaknesses
Table 71. RoslinCT Basic Information, Area Served and Competitors
Table 72. RoslinCT Major Business
Table 73. RoslinCT Cell and Gene Therapy CDMO Product and Services
Table 74. RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. RoslinCT Recent Developments/Updates
Table 76. RoslinCT Competitive Strengths & Weaknesses
Table 77. Thermo Scientific Basic Information, Area Served and Competitors
Table 78. Thermo Scientific Major Business
Table 79. Thermo Scientific Cell and Gene Therapy CDMO Product and Services
Table 80. Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Scientific Recent Developments/Updates
Table 82. Thermo Scientific Competitive Strengths & Weaknesses
Table 83. Mesoblast Basic Information, Area Served and Competitors
Table 84. Mesoblast Major Business
Table 85. Mesoblast Cell and Gene Therapy CDMO Product and Services
Table 86. Mesoblast Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Mesoblast Recent Developments/Updates
Table 88. Mesoblast Competitive Strengths & Weaknesses
Table 89. Cellularity Basic Information, Area Served and Competitors
Table 90. Cellularity Major Business
Table 91. Cellularity Cell and Gene Therapy CDMO Product and Services
Table 92. Cellularity Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Cellularity Recent Developments/Updates
Table 94. Cellularity Competitive Strengths & Weaknesses
Table 95. Bluebird Bio Basic Information, Area Served and Competitors
Table 96. Bluebird Bio Major Business
Table 97. Bluebird Bio Cell and Gene Therapy CDMO Product and Services
Table 98. Bluebird Bio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bluebird Bio Recent Developments/Updates
Table 100. Bluebird Bio Competitive Strengths & Weaknesses
Table 101. Editas Medicine Basic Information, Area Served and Competitors
Table 102. Editas Medicine Major Business
Table 103. Editas Medicine Cell and Gene Therapy CDMO Product and Services
Table 104. Editas Medicine Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Editas Medicine Recent Developments/Updates
Table 106. Editas Medicine Competitive Strengths & Weaknesses
Table 107. Andelyn Biosciences Basic Information, Area Served and Competitors
Table 108. Andelyn Biosciences Major Business
Table 109. Andelyn Biosciences Cell and Gene Therapy CDMO Product and Services
Table 110. Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Andelyn Biosciences Recent Developments/Updates
Table 112. Andelyn Biosciences Competitive Strengths & Weaknesses
Table 113. Wuxi Advanced Therapies Basic Information, Area Served and Competitors
Table 114. Wuxi Advanced Therapies Major Business
Table 115. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Services
Table 116. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Wuxi Advanced Therapies Recent Developments/Updates
Table 118. Wuxi Advanced Therapies Competitive Strengths & Weaknesses
Table 119. AGC Biologics Basic Information, Area Served and Competitors
Table 120. AGC Biologics Major Business
Table 121. AGC Biologics Cell and Gene Therapy CDMO Product and Services
Table 122. AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. AGC Biologics Recent Developments/Updates
Table 124. AGC Biologics Competitive Strengths & Weaknesses
Table 125. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 126. Pfizer CentreOne Major Business
Table 127. Pfizer CentreOne Cell and Gene Therapy CDMO Product and Services
Table 128. Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Pfizer CentreOne Recent Developments/Updates
Table 130. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 131. Almac Group Basic Information, Area Served and Competitors
Table 132. Almac Group Major Business
Table 133. Almac Group Cell and Gene Therapy CDMO Product and Services
Table 134. Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Almac Group Recent Developments/Updates
Table 136. PCI Pharma Services Basic Information, Area Served and Competitors
Table 137. PCI Pharma Services Major Business
Table 138. PCI Pharma Services Cell and Gene Therapy CDMO Product and Services
Table 139. PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Cell and Gene Therapy CDMO Upstream (Raw Materials)
Table 141. Cell and Gene Therapy CDMO Typical Customers
List of Figure
Figure 1. Cell and Gene Therapy CDMO Picture
Figure 2. World Cell and Gene Therapy CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell and Gene Therapy CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell and Gene Therapy CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell and Gene Therapy CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Cell and Gene Therapy CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy CDMO Markets in 2022
Figure 27. United States VS China: Cell and Gene Therapy CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell and Gene Therapy CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell and Gene Therapy CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell and Gene Therapy CDMO Market Size Market Share by Type in 2022
Figure 31. Clinical Trial Material CDMOs
Figure 32. Development and Manufacturing CDMOs
Figure 33. Other
Figure 34. World Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2029)
Figure 35. World Cell and Gene Therapy CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Cell and Gene Therapy CDMO Market Size Market Share by Application in 2022
Figure 37. Pharmaceutical Company
Figure 38. Biotechnology Company
Figure 39. Other
Figure 40. Cell and Gene Therapy CDMO Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Table 1. World Cell and Gene Therapy CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cell and Gene Therapy CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cell and Gene Therapy CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cell and Gene Therapy CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cell and Gene Therapy CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cell and Gene Therapy CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cell and Gene Therapy CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cell and Gene Therapy CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cell and Gene Therapy CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cell and Gene Therapy CDMO Players in 2022
Table 12. World Cell and Gene Therapy CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cell and Gene Therapy CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Cell and Gene Therapy CDMO Player
Table 15. Cell and Gene Therapy CDMO Market: Company Product Type Footprint
Table 16. Cell and Gene Therapy CDMO Market: Company Product Application Footprint
Table 17. Cell and Gene Therapy CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Cell and Gene Therapy CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cell and Gene Therapy CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cell and Gene Therapy CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cell and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 23. China Based Cell and Gene Therapy CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cell and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cell and Gene Therapy CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cell and Gene Therapy CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cell and Gene Therapy CDMO Revenue Market Share (2018-2023)
Table 29. World Cell and Gene Therapy CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cell and Gene Therapy CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cell and Gene Therapy CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cell and Gene Therapy CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cell and Gene Therapy CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cell and Gene Therapy CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Lonza Basic Information, Area Served and Competitors
Table 36. Lonza Major Business
Table 37. Lonza Cell and Gene Therapy CDMO Product and Services
Table 38. Lonza Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Lonza Recent Developments/Updates
Table 40. Lonza Competitive Strengths & Weaknesses
Table 41. Charles River Laboratories Basic Information, Area Served and Competitors
Table 42. Charles River Laboratories Major Business
Table 43. Charles River Laboratories Cell and Gene Therapy CDMO Product and Services
Table 44. Charles River Laboratories Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Charles River Laboratories Recent Developments/Updates
Table 46. Charles River Laboratories Competitive Strengths & Weaknesses
Table 47. Cytiva Basic Information, Area Served and Competitors
Table 48. Cytiva Major Business
Table 49. Cytiva Cell and Gene Therapy CDMO Product and Services
Table 50. Cytiva Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Cytiva Recent Developments/Updates
Table 52. Cytiva Competitive Strengths & Weaknesses
Table 53. Catalent Biologics Basic Information, Area Served and Competitors
Table 54. Catalent Biologics Major Business
Table 55. Catalent Biologics Cell and Gene Therapy CDMO Product and Services
Table 56. Catalent Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Catalent Biologics Recent Developments/Updates
Table 58. Catalent Biologics Competitive Strengths & Weaknesses
Table 59. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 60. FUJIFILM Diosynth Biotechnologies Major Business
Table 61. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Product and Services
Table 62. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 64. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 65. BioCentriq Basic Information, Area Served and Competitors
Table 66. BioCentriq Major Business
Table 67. BioCentriq Cell and Gene Therapy CDMO Product and Services
Table 68. BioCentriq Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. BioCentriq Recent Developments/Updates
Table 70. BioCentriq Competitive Strengths & Weaknesses
Table 71. RoslinCT Basic Information, Area Served and Competitors
Table 72. RoslinCT Major Business
Table 73. RoslinCT Cell and Gene Therapy CDMO Product and Services
Table 74. RoslinCT Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. RoslinCT Recent Developments/Updates
Table 76. RoslinCT Competitive Strengths & Weaknesses
Table 77. Thermo Scientific Basic Information, Area Served and Competitors
Table 78. Thermo Scientific Major Business
Table 79. Thermo Scientific Cell and Gene Therapy CDMO Product and Services
Table 80. Thermo Scientific Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Thermo Scientific Recent Developments/Updates
Table 82. Thermo Scientific Competitive Strengths & Weaknesses
Table 83. Mesoblast Basic Information, Area Served and Competitors
Table 84. Mesoblast Major Business
Table 85. Mesoblast Cell and Gene Therapy CDMO Product and Services
Table 86. Mesoblast Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Mesoblast Recent Developments/Updates
Table 88. Mesoblast Competitive Strengths & Weaknesses
Table 89. Cellularity Basic Information, Area Served and Competitors
Table 90. Cellularity Major Business
Table 91. Cellularity Cell and Gene Therapy CDMO Product and Services
Table 92. Cellularity Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Cellularity Recent Developments/Updates
Table 94. Cellularity Competitive Strengths & Weaknesses
Table 95. Bluebird Bio Basic Information, Area Served and Competitors
Table 96. Bluebird Bio Major Business
Table 97. Bluebird Bio Cell and Gene Therapy CDMO Product and Services
Table 98. Bluebird Bio Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Bluebird Bio Recent Developments/Updates
Table 100. Bluebird Bio Competitive Strengths & Weaknesses
Table 101. Editas Medicine Basic Information, Area Served and Competitors
Table 102. Editas Medicine Major Business
Table 103. Editas Medicine Cell and Gene Therapy CDMO Product and Services
Table 104. Editas Medicine Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Editas Medicine Recent Developments/Updates
Table 106. Editas Medicine Competitive Strengths & Weaknesses
Table 107. Andelyn Biosciences Basic Information, Area Served and Competitors
Table 108. Andelyn Biosciences Major Business
Table 109. Andelyn Biosciences Cell and Gene Therapy CDMO Product and Services
Table 110. Andelyn Biosciences Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Andelyn Biosciences Recent Developments/Updates
Table 112. Andelyn Biosciences Competitive Strengths & Weaknesses
Table 113. Wuxi Advanced Therapies Basic Information, Area Served and Competitors
Table 114. Wuxi Advanced Therapies Major Business
Table 115. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Product and Services
Table 116. Wuxi Advanced Therapies Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Wuxi Advanced Therapies Recent Developments/Updates
Table 118. Wuxi Advanced Therapies Competitive Strengths & Weaknesses
Table 119. AGC Biologics Basic Information, Area Served and Competitors
Table 120. AGC Biologics Major Business
Table 121. AGC Biologics Cell and Gene Therapy CDMO Product and Services
Table 122. AGC Biologics Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. AGC Biologics Recent Developments/Updates
Table 124. AGC Biologics Competitive Strengths & Weaknesses
Table 125. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 126. Pfizer CentreOne Major Business
Table 127. Pfizer CentreOne Cell and Gene Therapy CDMO Product and Services
Table 128. Pfizer CentreOne Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Pfizer CentreOne Recent Developments/Updates
Table 130. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 131. Almac Group Basic Information, Area Served and Competitors
Table 132. Almac Group Major Business
Table 133. Almac Group Cell and Gene Therapy CDMO Product and Services
Table 134. Almac Group Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Almac Group Recent Developments/Updates
Table 136. PCI Pharma Services Basic Information, Area Served and Competitors
Table 137. PCI Pharma Services Major Business
Table 138. PCI Pharma Services Cell and Gene Therapy CDMO Product and Services
Table 139. PCI Pharma Services Cell and Gene Therapy CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Cell and Gene Therapy CDMO Upstream (Raw Materials)
Table 141. Cell and Gene Therapy CDMO Typical Customers
List of Figure
Figure 1. Cell and Gene Therapy CDMO Picture
Figure 2. World Cell and Gene Therapy CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cell and Gene Therapy CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cell and Gene Therapy CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cell and Gene Therapy CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cell and Gene Therapy CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Cell and Gene Therapy CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cell and Gene Therapy CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cell and Gene Therapy CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cell and Gene Therapy CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy CDMO Markets in 2022
Figure 27. United States VS China: Cell and Gene Therapy CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cell and Gene Therapy CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cell and Gene Therapy CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cell and Gene Therapy CDMO Market Size Market Share by Type in 2022
Figure 31. Clinical Trial Material CDMOs
Figure 32. Development and Manufacturing CDMOs
Figure 33. Other
Figure 34. World Cell and Gene Therapy CDMO Market Size Market Share by Type (2018-2029)
Figure 35. World Cell and Gene Therapy CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Cell and Gene Therapy CDMO Market Size Market Share by Application in 2022
Figure 37. Pharmaceutical Company
Figure 38. Biotechnology Company
Figure 39. Other
Figure 40. Cell and Gene Therapy CDMO Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
